HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-[2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzoic Acid → HCID 10225261, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-[2-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzoic Acid | HCID 11220119 | — |
| Reactant | HCID 54694430 | HCID 54694430 | — |
| Reactant | HCID 131726920 | HCID 131726920 | — |
| Product | HCID 10225261 | HCID 10225261 | — |
Reaction Steps
2′-Methyl-N-4-[(methylamino)carbonyl]benzyl)5′-(5-methyl-1,3,4-oxadiazol-2-yl-1,1′-biphenyl-4-carboxamide was prepared from 2′-methyl-5′-(5-methyl-1,3,4-oxadiazol-2-yl)-1,1′-biphenyl-4-carboxylic acid and N-methyl-(4-aminomethylbenzyl)amide using method H. NMR; δH [2H6]—DMSO 9.18,(1H, t), 8.38,(1H, q), 8.01,(2H, d), 7.89, (1H, dd), 7.78,(3H, m), 7.54,(3H, m), 7.40,(2H, d), 4.55,(2H, d), 2.76,(3H, d), 2.56,(3H, s), 2.31,(3H, s). LCMS; retention time 2.88 min, MH+ 441.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07384963B2 |
| Source dataset | uspto-grants-2008_06 |
| ORD ID | ord-03dde4b34e6446e79c25ca58e083c3fb |
| Source note | uspto-grants-2008_06 |